Omega Healthcare Investors (NYSE:OHI) Coverage Initiated by Analysts at Berenberg Bank

Berenberg Bank began coverage on shares of Omega Healthcare Investors (NYSE:OHI) in a report published on Friday, MarketBeat reports. The firm issued a buy rating and a $45.00 price target on the real estate investment trust’s stock.

OHI has been the topic of a number of other reports. Mizuho lowered shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and raised their target price for the stock from $34.00 to $35.00 in a research report on Thursday, July 25th. Scotiabank upped their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th. BMO Capital Markets boosted their price objective on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a research note on Monday, October 7th. Truist Financial increased their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research report on Wednesday, September 4th. Finally, Wells Fargo & Company reiterated an “overweight” rating and issued a $43.00 target price (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Eight research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $37.80.

Omega Healthcare Investors Trading Up 2.1 %

OHI stock opened at $41.61 on Friday. The firm’s fifty day simple moving average is $39.71 and its two-hundred day simple moving average is $35.29. The stock has a market capitalization of $10.28 billion, a price-to-earnings ratio of 37.49, a price-to-earnings-growth ratio of 1.29 and a beta of 1.00. The company has a quick ratio of 5.79, a current ratio of 5.79 and a debt-to-equity ratio of 1.19. Omega Healthcare Investors has a twelve month low of $27.53 and a twelve month high of $41.62.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 EPS for the quarter, missing the consensus estimate of $0.65 by ($0.20). Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. The firm had revenue of $252.70 million for the quarter, compared to the consensus estimate of $205.92 million. During the same quarter in the previous year, the company posted $0.74 earnings per share. The business’s revenue for the quarter was up 17.5% on a year-over-year basis. As a group, analysts anticipate that Omega Healthcare Investors will post 2.69 earnings per share for the current year.

Omega Healthcare Investors Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Monday, August 5th were issued a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.44%. The ex-dividend date of this dividend was Monday, August 5th. Omega Healthcare Investors’s dividend payout ratio (DPR) is 241.44%.

Insider Buying and Selling

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares of the company’s stock, valued at $7,357,824.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of OHI. Daiwa Securities Group Inc. increased its stake in shares of Omega Healthcare Investors by 1,030.8% during the second quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust’s stock worth $32,384,000 after purchasing an additional 861,907 shares in the last quarter. Marshall Wace LLP purchased a new position in Omega Healthcare Investors during the second quarter worth approximately $20,962,000. BROOKFIELD Corp ON acquired a new position in Omega Healthcare Investors during the first quarter worth $16,446,000. Vanguard Group Inc. boosted its stake in Omega Healthcare Investors by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 35,214,682 shares of the real estate investment trust’s stock worth $1,079,682,000 after buying an additional 346,811 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in Omega Healthcare Investors by 7.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock valued at $127,831,000 after buying an additional 272,299 shares in the last quarter. Institutional investors and hedge funds own 65.25% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.